Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,880 | 1,186 | 99.8% |
| Education | $36.14 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,159 | 152 | $0 (2022) |
| Lilly USA, LLC | $2,022 | 212 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,795 | 117 | $0 (2022) |
| PFIZER INC. | $1,498 | 130 | $0 (2022) |
| Novo Nordisk Inc | $1,224 | 74 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $1,166 | 108 | $0 (2022) |
| Astellas Pharma US Inc | $841.09 | 62 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $835.52 | 47 | $0 (2022) |
| ABBVIE INC. | $831.77 | 52 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $681.23 | 52 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $2,160 | 143 | ABBVIE INC. ($406.59) |
| 2021 | $1,846 | 114 | Lilly USA, LLC ($305.75) |
| 2020 | $1,825 | 122 | Lilly USA, LLC ($422.09) |
| 2019 | $3,237 | 261 | GlaxoSmithKline, LLC. ($464.21) |
| 2018 | $3,655 | 289 | GlaxoSmithKline, LLC. ($605.28) |
| 2017 | $3,193 | 263 | GlaxoSmithKline, LLC. ($501.94) |
All Payment Transactions
1,192 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: PRIMARY CARE | ||||||
| 12/02/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: PRIMARY CARE | ||||||
| 10/28/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Diabetes | ||||||
| 10/27/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Respiratory | ||||||
| 10/27/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: PRIMARY CARE | ||||||
| 10/26/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: PRIMARY CARE | ||||||
| 10/26/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/21/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Diabetes | ||||||
| 10/20/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: RESPIRATORY | ||||||
| 10/20/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $2.63 | General |
| Category: Diabetes | ||||||
| 10/17/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: Diabetes | ||||||
| 10/14/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: Diabetes | ||||||
| 10/13/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: PRIMARY CARE | ||||||
| 10/13/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: PRIMARY CARE | ||||||
| 10/13/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $2.29 | General |
| Category: PRIMARY CARE | ||||||
| 10/11/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $3.23 | General |
| Category: PRIMARY CARE | ||||||
| 10/04/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Bone Health | ||||||
| 09/30/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: DIABETES | ||||||
| 09/27/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Diabetes | ||||||
| 09/23/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: PRIMARY CARE | ||||||
| 09/22/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 165 | 217 | $59,344 | $12,885 |
| 2022 | 5 | 144 | 214 | $30,533 | $14,524 |
| 2021 | 7 | 193 | 267 | $27,697 | $16,551 |
| 2020 | 9 | 223 | 290 | $28,973 | $14,964 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 29 | 29 | $13,630 | $3,443 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 60 | $15,960 | $3,305 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 38 | $15,858 | $2,926 | 18.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 23 | 34 | $10,370 | $1,798 | 17.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $920.00 | $833.91 | 90.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 14 | $910.00 | $413.14 | 45.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 14 | $1,101 | $94.86 | 8.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 17 | 17 | $595.00 | $71.88 | 12.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 65 | $11,705 | $5,817 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 59 | $7,855 | $3,306 | 42.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 24 | 24 | $5,500 | $2,967 | 54.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 22 | 37 | $4,420 | $2,218 | 50.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 27 | 29 | $1,053 | $215.19 | 20.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 59 | $9,735 | $5,083 | 52.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 25 | 25 | $4,375 | $3,243 | 74.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 48 | $6,000 | $3,001 | 50.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 23 | 45 | $3,600 | $2,453 | 68.1% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 30 | 30 | $2,100 | $1,993 | 94.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 31 | 31 | $930.00 | $512.12 | 55.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 26 | 29 | $957.00 | $265.88 | 27.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 39 | 86 | $13,902 | $5,693 | 41.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 27 | 27 | $4,725 | $3,054 | 64.6% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 31 | 31 | $1,860 | $1,860 | 100.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 25 | $3,077 | $1,297 | 42.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 17 | 25 | $1,790 | $1,232 | 68.8% |
About Dr. Sylvia Park, MD
Dr. Sylvia Park, MD is a Internal Medicine healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538183264.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sylvia Park, MD has received a total of $15,916 in payments from pharmaceutical and medical device companies, with $2,160 received in 2022. These payments were reported across 1,192 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($15,880).
As a Medicare-enrolled provider, Park has provided services to 725 Medicare beneficiaries, totaling 988 services with total Medicare billing of $58,925. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Rochester, NY
- Active Since 07/26/2006
- Last Updated 11/03/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1538183264
Products in Payments
- TRULICITY (Drug) $989.53
- XARELTO (Drug) $820.44
- FARXIGA (Drug) $808.22
- TRELEGY ELLIPTA (Drug) $726.40
- Ozempic (Drug) $673.19
- MYRBETRIQ (Drug) $552.46
- ELIQUIS (Drug) $549.46
- ANORO (Drug) $532.59
- SYMBICORT (Drug) $525.47
- Trintellix (Drug) $427.62
- NURTEC ODT (Drug) $384.17
- BASAGLAR (Drug) $374.99
- CHANTIX (Drug) $371.08
- BREO (Drug) $366.48
- EMGALITY (Drug) $336.92
- JARDIANCE (Drug) $310.36
- BREZTRI (Drug) $309.61
- INVOKANA (Drug) $306.94
- EUCRISA (Drug) $300.50
- Myrbetriq (Drug) $288.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rochester
Dr. Ben George, M.d, M.D
Internal Medicine — Payments: $729,795
John Kisiel, M.d, M.D
Internal Medicine — Payments: $550,377
Gregory Poland, M.d, M.D
Internal Medicine — Payments: $532,099
Christopher Ritchlin, Md, MD
Internal Medicine — Payments: $512,889
Scott Feitell, D.o, D.O
Internal Medicine — Payments: $471,187
Prashant Kapoor, Md, MD
Internal Medicine — Payments: $403,295